Showing results 1 to 20 of 38
next >
Issue Date | Title | Author(s) |
2009 | Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect | Huang, X-J; Wang, Y.; Liu, D-H; Xu, L-P; Liu, K-Y; Chen, H.; Chen, Y-H; Han, W.; Shi, H-X |
2017 | Adoptive transfer of CMV-specific T cells for persistent CMV infection after haploidentical stem cell transplantation: association between antiviral immunity and the improving of quantity and quality of CMV-specific T cells | Pei, X-Y; Zhao, X-Y; J-Liu; Chang, Y-J; Xu, L-P; Zhang, X-H; Han, W.; Chen, Y-H; Huang, X-J |
2017 | Adoptive transfer of CMV-specific T cells for persistent CMV infection after haploidentical stem cell transplantation: association between antiviral immunity and the improving of quantity and quality of CMV-specific T cells | Pei, X-Y; Zhao, X-Y; J-Liu; Chang, Y-J; Xu, L-P; Zhang, X-H; Han, W.; Chen, Y-H; Huang, X-J |
2014 | Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis | Jiang, H.; Xu, L-P; Liu, D-H; Liu, K-Y; Chen, S-S; Jiang, B.; Jiang, Q.; Chen, H.; Chen, Y-H; Han, W.; Zhang, H.; Wang, Y.; Wang, J-Z; Wang, F-R; Qin, Y-Z; Lai, Y-Y; Huang, X-J |
2017 | Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation | Bian, Z.; Liu, J.; Xu, L-P; Chang, Y-J; Wang, Y.; Zhang, X-H; Huang, X-J |
2017 | ATORVASTATIN IMPROVE THE PROGNOSIS OF ADULT PATIENTS WITH CORTICOSTEROID-RESISTANT IMMUNE THROMBOCYTOPENIA VIA ENHANCING BONE MARROW ENDOTHELIAL CELL FUNCTION | Kong, Y.; Cao, X-N; Zhang, X-H; Shi, M-M; Lai, Y-Y; Sun, Y-Q; Wang, Y.; Xu, L-P; Chang, Y-J; Huang, X-J |
2017 | ATORVASTATIN IMPROVE THE PROGNOSIS OF ADULT PATIENTS WITH CORTICOSTEROID-RESISTANT IMMUNE THROMBOCYTOPENIA VIA ENHANCING BONE MARROW ENDOTHELIAL CELL FUNCTION | Kong, Y.; Cao, X-N; Zhang, X-H; Shi, M-M; Lai, Y-Y; Sun, Y-Q; Wang, Y.; Xu, L-P; Chang, Y-J; Huang, X-J |
2016 | Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation | Yan, C-H; Xu, L-P; Wang, F-r; Chen, H.; Han, W.; Wang, Yu; Wang, J-z; Liu, K-Y; Huang, X-J |
2015 | Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome | Mo, X-D; Xu, L-P; Zhang, X-H; Liu, D-H; Wang, Y.; Chen, H.; Yan, C-H; Chen, Y-H; Han, W.; Wang, F-R; Wang, J-Z; Liu, K-Y; Huang, X-J |
2017 | Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation | Ma, Y-R; Xu, L-P; Zhang, X-H; Yan, C-H; Wang, Y.; Wang, F-R; Wang, J-Z; Chen, Y.; Han, W.; Chen, Y-H; Chen, H.; Liu, K-Y; Huang, X-J |
2017 | DYSFUNCTION OF BONE MARROW MESENCHYMAL STEM CELLS FROM PATIENTS WITH PROLONGED ISOLATED THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE IMPROVED BY N-ACETYL-L-CYSTEINE | Song, Y.; Kong, Y.; Tang, F-F; Zhao, H-Y; Chen, Y-H; Han, W.; Yan, C-H; Wang, Y.; Zhang, X-H; Xu, L-P; Huang, X-J |
2017 | DYSFUNCTION OF BONE MARROW MESENCHYMAL STEM CELLS FROM PATIENTS WITH PROLONGED ISOLATED THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE IMPROVED BY N-ACETYL-L-CYSTEINE | Song, Y.; Kong, Y.; Tang, F-F; Zhao, H-Y; Chen, Y-H; Han, W.; Yan, C-H; Wang, Y.; Zhang, X-H; Xu, L-P; Huang, X-J |
Nov-2022 | Glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage post chemotherapy and irradiation | Lyu, Z-S; Tang, S-Q; Xing, T.; Zhou, Y.; Lv, M.; Fu, H-X; Wang, Y.; Xu, L-P; Zhang, X-H; Lee, H-Y; Kong, Y.; Huang, X-J |
2014 | HAPLOIDENTIAL STEM CELL TRANSPLANTATION IS AN ATTRACTIVE ALTERNATIVE TREATMENT IN PATIENTS WITH BPDCN | Wang, F-R; Xu, L-P; Liu, D-H; Wang, Y.; Sun, Y-Q; Huang, X-J |
2015 | Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL | Sun, Y-Q; Wang, J.; Jiang, Q.; Xu, L-P; Liu, D-H; Zhang, X-H; Liu, K-Y; Huang, X-J |
2016 | Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant | Wang, Y.; Wang, H-X; Lai, Y-R; Sun, Z-M; Wu, D-P; Jiang, M.; Liu, D-H; Xu, K-L; Liu, Q-F; Liu, L.; Wang, J-B; Gao, F.; Ou-Yang, J.; Gao, S-J; Xu, L-P; Huang, X-J |
2014 | Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib | Mo, X-D; Jiang, Q.; Xu, L-P; Liu, D-H; Liu, K-Y; Jiang, B.; Jiang, H.; Chen, H.; Chen, Y-H; Zhang, X-H; Han, W.; Wang, Y.; Huang, X-J |
2014 | HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients | Zhao, X-Y; Chang, Y-J; Xu, L-P; Zhang, X-H; Liu, K-Y; Li, D.; Huang, X-J |
2017 | Hormone therapy for premature ovarian insufficiency patients with malignant hematologic diseases | Yang, X.; Wang, C.; He, X.; Wei, J.; Wang, Y.; Li, X.; Xu, L-P |
2013 | Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia | Jiang, Q.; Xu, L-P; Liu, D-H; Liu, K-Y; Gale, R. P.; Zhang, M-J; Jiang, B.; Zhang, X-H; Wang, Y.; Chen, S-S; Zhao, X-Y; Chen, H.; Jiang, H.; Chen, Y-H; Han, W.; Qin, Y-Z; Liu, Y-R; Lai, Y-Y; Lv, M.; Huang, X-J |